Commonwealth Equity Services’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57K | Buy |
18,161
+5,464
| +43% | +$17.1K | ﹤0.01% | 4138 |
|
|
2025
Q1 | $45K | Buy |
+12,697
| New | +$45K | ﹤0.01% | 4077 |
|
|
2024
Q1 | – | Sell |
-58,848
| Closed | -$252K | – | 4062 |
|
|
2023
Q4 | $252K | Buy |
58,848
+43,480
| +283% | +$186K | ﹤0.01% | 3324 |
|
|
2023
Q3 | $52K | Sell |
15,368
-1,445
| -9% | -$4.89K | ﹤0.01% | 3656 |
|
|
2023
Q2 | $95K | Sell |
16,813
-3,373
| -17% | -$19.1K | ﹤0.01% | 3579 |
|
|
2023
Q1 | $97 | Buy |
+20,186
| New | +$97 | ﹤0.01% | 3500 |
|